Research Grants
Funding For:
GLP-1 Adoption and Its Downstream Effects on Health Spending and Utilization Among Privately Insured Adults with Diabetes and Obesity
Health Care Management / Affordability / Cost & Quality / Prescription Drugs
Recipient:
Sih-Ting Cai, Indiana University
Grant Period:
Jan 01, 2026 - Dec 31, 2026
AMOUNT:
$49,970.00
Summary of the Project:
The rise of GLP-1 medications is contributing to the rapid growth in spending. This study will estimate the impact of GLP-1 initiation on downstream (non-GLP-1) health care spending and clinical utilization among commercially insured adults with type 2 diabetes or obesity. The study will provide evidence on whether GLP-1 use “pays for itself” in real-world settings.
Research Team:
Coady Wing, Indiana University
Sih-Ting Cai, Indiana University
Daniel W Sacks, University of Wisconsin - Madison
Kosali I Simon, Indiana University